Tenogenic Contribution to Skeletal Muscle Regeneration: The Secretome of Scleraxis Overexpressing Mesenchymal Stem Cells Enhances Myogenic Differentiation In Vitro.
RNA-Seq
mesenchymal stem cells
myotendinous junction
regenerative medicine
satellite cell
scleraxis
skeletal muscle
tendon-muscle crosstalk
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Mar 2020
13 Mar 2020
Historique:
received:
11
02
2020
revised:
09
03
2020
accepted:
12
03
2020
entrez:
19
3
2020
pubmed:
19
3
2020
medline:
2
12
2020
Statut:
epublish
Résumé
Integrity of the musculoskeletal system is essential for the transfer of muscular contraction force to the associated bones. Tendons and skeletal muscles intertwine, but on a cellular level, the myotendinous junctions (MTJs) display a sharp transition zone with a highly specific molecular adaption. The function of MTJs could go beyond a mere structural role and might include homeostasis of this musculoskeletal tissue compound, thus also being involved in skeletal muscle regeneration. Repair processes recapitulate several developmental mechanisms, and as myotendinous interaction does occur already during development, MTJs could likewise contribute to muscle regeneration. Recent studies identified tendon-related, scleraxis-expressing cells that reside in close proximity to the MTJs and the muscle belly. As the muscle-specific function of these scleraxis positive cells is unknown, we compared the influence of two immortalized mesenchymal stem cell (MSC) lines-differing only by the overexpression of scleraxis-on myoblasts morphology, metabolism, migration, fusion, and alignment. Our results revealed a significant increase in myoblast fusion and metabolic activity when exposed to the secretome derived from scleraxis-overexpressing MSCs. However, we found no significant changes in myoblast migration and myofiber alignment. Further analysis of differentially expressed genes between native MSCs and scleraxis-overexpressing MSCs by RNA sequencing unraveled potential candidate genes, i.e., extracellular matrix (ECM) proteins, transmembrane receptors, or proteases that might enhance myoblast fusion. Our results suggest that musculotendinous interaction is essential for the development and healing of skeletal muscles.
Identifiants
pubmed: 32183051
pii: ijms21061965
doi: 10.3390/ijms21061965
pmc: PMC7139530
pii:
doi:
Substances chimiques
Basic Helix-Loop-Helix Transcription Factors
0
SCX protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medizinischen Fakultät, Ludwig-Maximilians-Universität München
ID : FöFoLe 955
Organisme : Medizinischen Fakultät, Ludwig-Maximilians-Universität München
ID : MolMed 05/2018
Références
Am J Sports Med. 2005 May;33(5):745-64
pubmed: 15851777
Exerc Sport Sci Rev. 2009 Jan;37(1):18-22
pubmed: 19098520
J Cell Mol Med. 2008 Aug;12(4):1347-59
pubmed: 18318690
J Biol Chem. 2003 Apr 11;278(15):12601-4
pubmed: 12556454
J Biophys Biochem Cytol. 1961 Feb;9:493-5
pubmed: 13768451
Dev Biol. 2007 Feb 1;302(1):267-80
pubmed: 17070795
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Development. 2004 Aug;131(16):3885-96
pubmed: 15253939
Exp Cell Res. 2001 Aug 1;268(1):36-44
pubmed: 11461116
Front Cell Dev Biol. 2017 Mar 23;5:22
pubmed: 28386539
J Intern Med. 2009 Oct;266(4):372-89
pubmed: 19765181
J Exp Med. 2007 May 14;204(5):1057-69
pubmed: 17485518
Autophagy. 2016;12(2):369-80
pubmed: 26566717
Nat Cell Biol. 2010 Feb;12(2):153-63
pubmed: 20081841
Mol Ther. 2012 Jan;20(1):146-54
pubmed: 21934656
Physiol Rev. 2013 Jan;93(1):23-67
pubmed: 23303905
Genome Biol. 2014;15(12):550
pubmed: 25516281
Development. 2012 Feb;139(4):641-56
pubmed: 22274696
Sci Transl Med. 2018 Jan 31;10(426):
pubmed: 29386358
Exp Cell Res. 2002 Nov 1;280(2):169-78
pubmed: 12413883
Cell. 2000 Sep 15;102(6):777-86
pubmed: 11030621
Cell Rep. 2017 Nov 14;21(7):1994-2004
pubmed: 29141228
Stem Cells Dev. 2012 Apr 10;21(6):846-58
pubmed: 21988170
Development. 1998 Oct;125(20):4019-32
pubmed: 9735363
Methods Enzymol. 2012;504:183-200
pubmed: 22264535
Cell Stem Cell. 2017 Jan 5;20(1):56-69
pubmed: 27840022
J Bone Joint Surg Br. 1985 Nov;67(5):820-8
pubmed: 3902851
J Cell Sci. 2010 Sep 15;123(Pt 18):3052-60
pubmed: 20736301
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Mol Cell. 2019 May 2;74(3):609-621.e6
pubmed: 30922843
Dev Biol. 1986 May;115(1):140-7
pubmed: 3699242
Am J Physiol Cell Physiol. 2003 Aug;285(2):C370-6
pubmed: 12711593
J Muscle Res Cell Motil. 2008;29(1):37-44
pubmed: 18563597
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Science. 2001 Apr 27;292(5517):737-40
pubmed: 11326102
Curr Top Dev Biol. 2011;96:139-65
pubmed: 21621070
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Development. 2019 Jun 28;146(13):
pubmed: 31253633
Am J Pathol. 2009 Feb;174(2):541-9
pubmed: 19147819
Cell. 2013 Dec 5;155(6):1282-95
pubmed: 24315098
J Cell Physiol. 1995 Nov;165(2):307-12
pubmed: 7593208
Nat Commun. 2018 Sep 10;9(1):3670
pubmed: 30202063
Cell. 2003 Apr 18;113(2):235-48
pubmed: 12705871
Cell Death Dis. 2015 Jul 23;6:e1830
pubmed: 26203859
Cell Adh Migr. 2013 Jan-Feb;7(1):111-21
pubmed: 23154401
Cell Death Discov. 2017 Apr 10;3:17003
pubmed: 28417015